Assembly Biosciences (ASMB) EBT Margin (2017 - 2026)
Assembly Biosciences (ASMB) posted quarterly EBT Margin of 142.42% for Q1 2026, down 3643.0% year-over-year from 4.02% in Q1 2025, and down 373.81% quarter-over-quarter from 52.01% in Q4 2025.
Powered by 
Analysis
Assembly Biosciences (ASMB) EBT Margin (2017 - 2026) Analysis & Trends
Assembly Biosciences' EBT Margin history runs 9 years deep, the most recent figure standing at 142.42% for Q1 2026.
- In Q1 2026, EBT Margin fell 3643.0% year-over-year to 142.42%; the TTM figure through Mar 2026 stood at 12.66% (up 11408.0% YoY), while the FY2025 annual figure was 8.47%, up 13125.0% from the prior year.
- EBT Margin for Q1 2026 stood at 142.42%, down from 52.01% in the prior quarter.
- The five-year high for EBT Margin was 52.01% in Q4 2025, with the low at 156.91% in Q1 2024.
- The 4-year median for EBT Margin is 133.19% (2024), against an average of 110.49%.
- The sharpest annual moves came in 2025 and 2026: EBT Margin soared 19353 bps in 2025, then sank 3643 bps in 2026.
- Assembly Biosciences' EBT Margin stood at 152.58% in 2023, then climbed by 7 bps to 141.51% in 2024, then surged by 137 bps to 52.01% in 2025, then tumbled by 374 bps to 142.42% in 2026.
- Business Quant data shows ASMB's EBT Margin at 142.42% in Q1 2026, 52.01% in Q4 2025, and 85.23% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 12.09% |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -2.67% |
| 10 | Assembly Biosciences | 689.20 Mn | 368.83 Mn | - | -28.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.84% |
| Mar 31, 2026 | -110.54% |
| Dec 31, 2025 | 52.01% |
| Sep 30, 2025 | -85.23% |
| Jun 30, 2025 | -105.94% |
| Mar 31, 2025 | -93.62% |
| Dec 31, 2024 | -141.51% |
| Sep 30, 2024 | -140.44% |
| Jun 30, 2024 | -125.93% |
| Mar 31, 2024 | -156.91% |
| Dec 31, 2023 | -152.58% |
| Sep 30, 2021 | -300.66% |
| Dec 31, 2020 | -3,801.16% |
| Sep 30, 2020 | -9.68% |
| Jun 30, 2020 | 18.46% |
| Mar 31, 2020 | -653.15% |
| Dec 31, 2019 | -583.70% |
| Sep 30, 2019 | -591.11% |
| Jun 30, 2019 | -601.10% |
| Mar 31, 2019 | -696.50% |